• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Israeli Hospital Launches Rapid COVID-19 Detection Tests Pilot Program

by Jasmine Pennic 07/23/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Israeli Hospital Launches Rapid COVID-19 Detection Tests Pilot Program

What You Should Know:

– The Middle East’s largest hospital, Sheba Medical Center in Israel, just launched a breakthrough rapid COVID-19 detection test pilot program that enhances virus detection spectral technology and adapts it into rapid coronavirus testing.

– The innovative process uses an artificial intelligence algorithm to separate the profile of a person infected with a specific virus, from someone else who has a different virus or that of another healthy person.


 Israel’s Sheba Medical Center, Tel HaShomer, the largest hospital in the Middle East, announces the launch of a pilot program for breakthrough rapid COVID-19 detection tests conceived by Newsight Imaging, an Israeli startup. 

Rapid COVID-19 Detection Tests Pilot Program Overview

Sheba’s pilot program will conduct tests using Newsight’s revolutionary spectral device based on its developed Spectrometer-on-Chip. The device, which is about the size of a computer mouse, can identify and classify evidence of a virus in the body in less than one second, using a sample of fluid (blood serum or saliva sample) inserted into a disposable test cuvette. 

This spectral technology for virus detection itself is not the actual innovation, however. The new technological advance is Newsight’s ability to bring an expensive device that typically costs hundreds of thousands of dollars to be implemented in a single cost-effective chip, using an AI algorithm to separate the profile of a human infected with a specific virus, from a human infected with a different virus or from a healthy human. 

Newsight’s device simultaneously checks 1024 spectral channels, currently in the visible light spectrum of 400-700 nm. During the next few months, the company plans to present a device that will be capable of examining a spectral profile in wavelengths of up to 1100 nm. 

Medical experts in the infectious and tropical disease departments at Sheba Medical Center are already working with Newsight. Initial feasibility studies of the device have shown an ability to separate between alpha-coronaviruses (Alpha-CoV) and beta-coronaviruses (Beta-CoV), with an accuracy close to 100 percent, in addition to feasibility studies conducted on blood serum samples of people infected with the Dengue virus, which were found to be extremely accurate.

Future Plans

Newsight and Sheba’s ARC Innovation Center headed by Dr. Eyal Zimlichman, Chief Medical and Innovation Center at Sheba Medical Center, are planning to establish a joint company that will make these solutions commercially available to the medical community worldwide. Newsight Imaging’s previous machine vision chips are already integrated in dozens of different devices and solutions in the automotive, robotics, and advanced industrial manufacturing fields. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, Coronavirus (COVID-19), Israeli digital health startups, Sheba Medical Center

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |